Trade Moderna Inc ^MRNA

Moderna (NASDAQ:MRNA) Coverage Initiated by Analysts at Wolfe Research

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Metagenomi, Inc.(MGX) Shareholders | Morningstar

Vaccine maker stocks fall in US after Trump picks anti-vaccine activist RFK Jr as health secretary

Vaccine maker stocks fall as Trump chooses RFK Jr. to lead HHS

Lexeo Therapeutics, Inc. (LXEO) Gets a Buy from RBC Capital | Markets Insider

Moderna stock touches 52-week low at $41.52 amid market challenges By Investing.com

Health Care Down as Vaccine Makers Slide — Health Care Roundup | Morningstar

Lawsuits Mount Over Moderna's RSV Vaccine

Rakuten Securities Inc. Purchases 778 Shares of Moderna, Inc. (NASDAQ:MRNA)

Principal Financial Group Inc. Raises Holdings in Moderna, Inc. (NASDAQ:MRNA)

Principal Financial Group Inc. Buys 15,218 Shares of Moderna, Inc. (NASDAQ:MRNA)

Moderna Stock Outlook: Is Wall Street Bullish or Bearish?

NASDAQ: MGX DEADLINE REMINDER: Berger Montague Reminds Metagenomi (NASDAQ: MGX) Investors of Important Class Action Lawsuit Deadline | Morningstar

Moderna Tops BioSpace's Best Places to Work Ranking for Fourth Consecutive Year | Morningstar

Baillie Gifford & Co. Decreases Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)

BioSpace Announces 2025 Best Places to Work in Life Sciences Winners | Morningstar

Moderna COVID vaccine deal worth $2b blasted

Moderna (NASDAQ:MRNA) Hits New 1-Year Low on Analyst Downgrade

Intrinsic Value Partners LLC Increases Stake in Moderna, Inc. (NASDAQ:MRNA)

Moderna Sees Revenue Plummet by 44% through September, But Cuts Losses

Shareholders that lost money on Metagenomi, Inc.(MGX) should contact The Gross Law Firm about pending Class Action - MGX | Morningstar

Cautious Outlook on Moderna: Declining Vaccine Demand and Strategic Challenges Prompt Sell Rating

Privium Fund Management B.V. Purchases 17,221 Shares of Moderna, Inc. (NASDAQ:MRNA)

SpiderRock Advisors LLC Increases Stake in Moderna, Inc. (NASDAQ:MRNA)

Moderna (NASDAQ:MRNA) Announces Quarterly Earnings Results

Moderna (NASDAQ:MRNA) Given Hold Rating at Needham & Company LLC

Health Canada approves Moderna’s mRNA RSV vaccine, company says

Personalis, Inc. (NASDAQ:PSNL) Q3 2024 Earnings Call Transcript

mRESVIA is Moderna's second approved product in Canada, the

ARK Investment Management LLC Has $77.79 Million Stake in Moderna, Inc. (NASDAQ:MRNA)

Gulf International Bank UK Ltd Sells 1,186 Shares of Moderna, Inc. (NASDAQ:MRNA)

Shareholders that lost money on Metagenomi, Inc.(MGX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More | Morningstar

Moderna, Inc. (NASDAQ:MRNA) Holdings Lifted by Asset Management One Co. Ltd.

Moderna's RSV vaccine mRESVIA approved in Canada By Investing.com

MGX DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MGX | Morningstar

Moderna (NASDAQ:MRNA) Shares Gap Up - Here's Why

Shareholders that lost money on Metagenomi, Inc. (MGX) should contact Levi & Korsinsky about pending Class Action - MGX | Morningstar

Moderna sales get lift from early nod for newest COVID shot

Personalis Inc (PSNL) Q3 2024 Earnings Call Highlights: Robust Revenue Growth Amid Strategic ... By GuruFocus

Moderna adjusts to life after COVID By Proactive Investors

Moderna tops quarterly expectations

Moderna shares surge after vaccine maker's posts shallower-than-expected loss By Investing.com

Reports third quarter revenues of $1.9 billion, GAAP net inc

Moderna Turns To Profit In Q3; Backs FY24 Net Product Sales View; Stock Up

Class Action Filed Against Metagenomi, Inc. (MGX) Seeking Recovery for Investors - Contact The Gross Law Firm | Morningstar

Moderna reports surprise profit on higher-than-expected Covid vaccine sales

Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take hold

Moderna shares surge after vaccine maker posts unexpected third-quarter profit By Investing.com

Moderna earnings beat by $1.95, revenue topped estimates By Investing.com

Moderna's stock pops after biotech ekes out a surprise profit, and revenue beats by a wide margin | Morningstar

Moderna's stock pops after biotech ekes out profit and revenue beats by a wide margin | Morningstar

Moderna's stock soars 10% after biotech ekes out surprise profit and revenue beats by a wide margin | Morningstar

Moderna Stock Rises on Q3 Earnings & Sales Beat, Reiterates View - November 7, 2024 - Zacks.com

Stock market today: S&P 500 clinches another record after Fed cuts rates again By Investing.com

National Pension Service Has $54.39 Million Stake in Moderna, Inc. (NASDAQ:MRNA)

Van ECK Associates Corp Has $17.84 Million Position in Moderna, Inc. (NASDAQ:MRNA)

Known Agency Named Moderna's Media Agency Of Record 11/06/2024

Moderna (NASDAQ:MRNA) Reaches New 1-Year Low Following Analyst Downgrade

Moderna’s Bancel Steps Down as Sales Chief, Keeps CEO Role (1)

Moderna stock touches 52-week low at $52.21 amid market shifts By Investing.com

METAGENOMI (NASDAQ: MGX) INVESTOR ALERT: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action | Morningstar

TC Biopharm (NASDAQ:TCBP) vs. Moderna (NASDAQ:MRNA) Critical Comparison

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 25, 2024 in Metagenomi Lawsuit - MGX | Morningstar

Moderna CEO Bancel steps down as sales chief, Bloomberg Law reports By Reuters

What's in Store for These 5 Drug & Biotech Stocks in Q3 Earnings? - November 5, 2024 - Zacks.com

Should Moderna Stock Be in Your Portfolio Pre-Q3 Earnings? - November 5, 2024 - Zacks.com

Moderna (NASDAQ:MRNA) Price Target Cut to $59.00 by Analysts at JPMorgan Chase & Co.

Focus Financial Network Inc. Sells 819 Shares of Moderna, Inc. (NASDAQ:MRNA)

Nisa Investment Advisors LLC Sells 63,639 Shares of Moderna, Inc. (NASDAQ:MRNA)

Moderna (MRNA) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - November 4, 2024 - Zacks.com

MGX DEADLINE NOTICE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MGX | Morningstar

MGX Deadline: MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Lawsuit | Morningstar

DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors of Metagenomi to Contact Us to Have Their Losses Evaluated Today | Morningstar

abrdn plc Cuts Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)

Investors who lost money on Metagenomi, Inc.(MGX) should contact Levi & Korsinsky about pending Class Action - MGX | Morningstar

Moderna (MRNA): Expanding Horizons in Gene Editing and mRNA Vaccines

Moderna, Inc. (NASDAQ:MRNA) Shares Acquired by Meitav Investment House Ltd.

Metagenomi, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before November 25, 2024 to Discuss Your Rights - MGX | Morningstar

Moderna (MRNA) Scheduled to Post Earnings on Thursday

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi | Morningstar

Analysts Estimate Moderna (MRNA) to Report a Decline in Earnings: What to Look Out for - October 31, 2024 - Zacks.com

Is Moderna, Inc. (MRNA) The Worst Performing S&P 500 Stock In 2024?

Shareholders that lost money on Metagenomi, Inc.(MGX) should contact Levi & Korsinsky about pending Class Action - MGX | Morningstar

International Assets Investment Management LLC Increases Stock Position in Moderna, Inc. (NASDAQ:MRNA)

Carisma shares climb on EF Hutton Buy rating By Investing.com

Novocure Appoints Christoph Brackmann as CFO By Investing.com

Moderna Board, Top Execs Sued Over Statements About RSV Vaccine

Fed Hints at Tight Policy Amid Global Economic Uncertainty

Dogecoin surges after Elon Musk issues crypto endorsement

Week ahead: Tech rally hinges on Nvidia earnings

Stock Market Today: Indexes Drop as Fed Rate Cuts are still underway

What's Going On With Amazon Stock today? Is AMZN expected to rise?

Dogecoin surges as Trump unveils new government efficiency initiative with Musk andRamaswamy

Japanese Yen to USD: Yen drops to fresh multi-month low against USD

Asia markets today: Nikkei 225 up 0.18%, Hang Seng Index falls by 197 points